health medicine psychiatry regulation

The hidden dangers of a common hair-loss drug

For millions of men, finasteride has been marketed as a simple solution to hair loss. Approved by the U. S. Food and Drug Administration (FDA) in 1997, the drug promised to slow or even reverse male pattern baldness. But beneath its cosmetic appeal, a growing body of research has revealed a troubling reality: finasteride is consistently [.] The post The hidden dangers of a common hair-loss drug appeared first on Knowridge Science Report.

business cryptocurrency Finance investment regulation

Grayscale Seeks Big Breakthrough: Amended S-1 Filed To Convert Dogecoin Trust Into GDOG ETF

Grayscale Investments, one of the largest digital asset management firms in the world, has made another bold move in the crypto ETF space. The company recently submitted an amended S-1 registration statement to the US Securities and Exchange Commission (SEC), this time for its Dogecoin product. The filing reveals Grayscales intention to convert its existing [.].